Additional research on biomarkers in "Phase II study of cetuximab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer (JACCRO CC-08) "
Not Applicable
- Conditions
- Colorectal Cancer
- Registration Number
- JPRN-UMIN000015914
- Lead Sponsor
- Japan Clinical Cancer Research Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who are regarded as inadequate for study enrollment by investigators (2) Patients who refuse to supply the section
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor-related gene variation analysis using plasma free DNA
- Secondary Outcome Measures
Name Time Method The measurement in Cancer Panel